Search Results 31-40 of 16389 for immunothérapie effets secondaires

  1. Mayo Clinic Study Finds Immunotherapy May be Option Challenging Breast Cancer

    Triple negative breast cancer is an aggressive form of breast cancer that evades the immune system because it lacks expression of genes for estrogen receptor, ...

  2. Breast cancer treatment Archives - Mayo Clinic News Network

    mentioned using immunotherapy. What is immunotherapy, and how does it differ from chemotherapy, which I've traditionally heard about for treating cancer ...

  3. Testing The Addition Of An Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery To The Usual Surgery Alone For Treating Advanced Skin Cancer - Mayo Clinic

    The usual treatment for patients with resectable squamous cell skin cancer is the removal of the cancerous tissue (surgery) with or without radiation, which ...

  4. Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma - Mayo Clinic

    Giving immunotherapy before surgery may be more effective at controlling disease in patients with sarcomatoid mesothelioma than giving immunotherapy alone.

  5. Cancer survivors: Late effects of cancer treatment - Mayo Clinic

    These include chemotherapy, hormone therapy, radiation, surgery, targeted therapy and immunotherapy. As newer cancer treatments become available, these ...

  6. Predicting Immunotherapy Response in Metastatic Kidney Cancer - Mayo Clinic

    About this study. Immunotherapy has revolutionized the therapeutic landscape for patients with metastatic RCC and response rates are higher than previously ...

  7. Mayo Clinic researchers find enhancing the body's 'first responder' cells may boost immune therapy for cancer

    Mayo Clinic researchers discovered targeting myeloid cells can boost cancer immunotherapy by enhancing T-cell activity and overcoming resistance.

  8. A Study to Evaluate Immunotherapy for Non-Small Cell Lung Cancer - Mayo Clinic

    About this study. The primary objectives of this study are to evaluate safety/tolerability and immunogenicity of IMU-201 as monotherapy and in combination ...

  9. Many ophthalmic irAEs can be treated without discontinuation of life-prolonging immunotherapy - Mayo Clinic

    Dr. Dalvin and fellow researchers hypothesized that most ophthalmic irAEs can be managed with targeted therapy and should not require cessation of immunotherapy ...

  10. Oxaliplatin (intravenous route) - Side effects & uses - Mayo Clinic

    Oxaliplatin injection is given along with other medicines (eg, fluorouracil, leucovorin) to treat advanced cancer of the colon or rectum. It is also used to ...